Day: August 23, 2024

BULGOLD Announces Filing of Second Quarter Financial Results for Three and Six Months Ended June 30, 2024

TORONTO, Aug. 23, 2024 (GLOBE NEWSWIRE) — BULGOLD Inc. (TSXV: ZLTO) (the “Company” or “BULGOLD”) is pleased to announce that it has filed its unaudited condensed interim financial statements and MD&A for the second quarter ended June 30, 2024. During the three and six months ended June 30, 2024, the Company incurred a net loss of $135,643 ($0.00 per share) and $374,622 ($0.01 per share) respectively. On June 30, 2024, the company had cash (and cash equivalents) of $1,401,853 (net working capital of $855,519) which will be used to support exploration activities. About BULGOLD Inc. BULGOLD is a gold exploration company focused on the exploration and development of mineral exploration projects in Central and Eastern Europe. The Company controls 100% of three quality quartz-adularia epithermal gold projects located in the Bulgarian...

Continue reading

Montana Technologies Announces Second Quarter 2024 Results

RONAN, Mont., Aug. 23, 2024 (GLOBE NEWSWIRE) — Montana Technologies Corporation (NASDAQ: AIRJ) (“Montana Technologies” or the “Company”), the developer of the transformational AirJoule® technology for water generation, today announced its second quarter results. 2nd Quarter and Recent Highlights Global MOU Announcements: United Arab Emirates: Announced agreement with TenX Investment (“TenX”) to explore a deployment of AirJoule® units in support of water security and sustainability projects in the United Arab Emirates Australia: Announced agreement with Climate Impact Corporation (“CIC”) to collaborate on solar-powered hydrogen production using AirJoule® technology in Australia Continued advancement towards commercialization of AirJoule® applications in dehumidification and atmospheric water generation Commenced the build-out...

Continue reading

OKYO Pharma CEO Interview to Air on Bloomberg TV

LONDON and NEW YORK, Aug. 23, 2024 (GLOBE NEWSWIRE) — OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of inflammatory dry eye disease (DED), a multi-billion-dollar market, and anterior ocular segment diseases including neuropathic corneal pain (NCP), an ocular condition associated with pain but without an FDA approved therapy, announced today an interview with its CEO, Dr. Gary S. Jacob will air on The RedChip Small Stocks, Big Money™ show on Bloomberg TV, this Saturday, August 24, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S. In an exclusive interview, Gary S. Jacob, PhD, CEO of OKYO Pharma, appears on the RedChip Small Stocks Big Money™ show on Bloomberg TV to provide...

Continue reading

Nuwellis Announces Pricing of $916,000 Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

MINNEAPOLIS, Aug. 23, 2024 (GLOBE NEWSWIRE) — Nuwellis, Inc. (Nasdaq: NUWE) (“Nuwellis” or the “Company”), a medical technology company focused on transforming the lives of people with fluid overload, today announced that it has entered into a definitive securities purchase agreement with certain institutional investors for the purchase and sale of 496,901 shares of the Company’s common stock at a price of $1.8450 per share of common stock in a registered direct offering priced at-the-market under Nasdaq rules. In addition, in a concurrent private placement, the Company will issue to the investors warrants to purchase up to 496,901 shares of common stock. The warrants have an exercise price of $1.72 per share, will be exercisable immediately following the date of issuance and will have a term of five years from the date of effectiveness...

Continue reading

Intelligent Process Automation Market is Poised to Generate CAGR of 13.6% by 2031 | SkyQuest

Westford, USA, Aug. 23, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the Global Intelligent Process Automation Market will attain a value of USD 41.59 Billion by 2031, growing at a CAGR of 13.6% during the forecast period (2024-2031). The global intelligent process automation market will be growing in the future due to the rising need for increased productivity in business and technology penetration. It is an intelligent process automation solution that empowers end-users with advanced tools and agile processes to make rapid, more informed decisions. These solutions oversee and control the interfaces to overcome inefficiencies in workflow systems. In the coming years, this component is expected to generate market momentum. Automation is changing both front-end and back-office corporate processes. One of the key drivers of market...

Continue reading

Electric Bike Market to Attain Worth of USD 78.48 Billion by 2031 | SkyQuest

Westford, USA, Aug. 23, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the global electric bike market will attain a value of USD 78.48 Billion by 2031, with a CAGR of 6.9% over the forecast period (2024-2031). The implementation of government regulations to encourage the use of electric bikes, consumer preference for e-bikes as an efficient and environmentally friendly mode of transportation, rising fuel prices, and growing interest in cycling as a sport and leisure activity are all expected to drive market growth. Furthermore, the industry’s ongoing technological advancements are another reason driving up e-bike sales. For instance, connected e-bikes feature a SIM module that allows them to send and receive data over the cloud even when not linked to a smartphone. These motorcycles have remote diagnostics, built-in navigation,...

Continue reading

Veterinary Vaccines Market is Poised to Grow at CAGR of 6.2% by 2031 | SkyQuest

Westford, USA, Aug. 23, 2024 (GLOBE NEWSWIRE) — Global Veterinary vaccines market size was valued at USD 8.00 billion in 2022 and is poised to grow from USD 8.50 billion in 2023 to USD 13.75 billion by 2031, at a CAGR of 6.2% during the forecast period (2024-2031). Download a detailed overview: https://www.skyquestt.com/sample-request/veterinary-vaccines-market The increasing cases of zoonotic diseases are predicted to increase demand for animal vaccines, as they affect animal health and human health, besides posing a threat to food security. More massive human and animal populations living close to each other tend to tip the natural environment out of balance and raise the level of worldwide trade and travel that may hasten the potential pace for infection transmission across species. The demand for animal protein has driven...

Continue reading

High Wire Reports Q2 2024 Revenue up 14% to $1.9 Million; Net Income of $4.8 Million

BATAVIA, Ill., Aug. 23, 2024 (GLOBE NEWSWIRE) — High Wire Networks, Inc. (OTCQB: HWNI), a leading global provider of managed cybersecurity, reported results for continuing operations for the three months and six months ended June 30, 2024. All comparisons are to the same year-ago period unless otherwise noted. Q2 2024 Operational Highlights On June 27, 2024, High Wire sold its technology enablement services business in a transaction valued at $11.2 million. Proceeds from the sales of the technology enablement business were used to reduce debt by approximately $5 million, including eliminating approximately $1.1 million in convertible debentures, $3.2 million in notes payable, and a factoring facility. The company was also able to restructure the remaining debt of $3.1 million, including a reduction of $1.3 million in principle...

Continue reading

The GDL Fund Declares Third Quarter Distribution of $0.12 Per Share

RYE, N.Y., Aug. 23, 2024 (GLOBE NEWSWIRE) — The Board of Trustees of The GDL Fund (NYSE:GDL) (the “Fund”) declared a $0.12 per share cash distribution payable on September 23, 2024 to common shareholders of record on September 16, 2024. The Board of Trustees will continue to monitor the Fund’s distribution level, taking into consideration the Fund’s net asset value and the financial market environment. The distribution rate should not be considered the dividend yield or total return on an investment in the Fund. The Fund makes annual distributions of its realized net long-term capital gains and quarterly cash distributions of all or a portion of its investment company taxable income to common shareholders. A portion of the distribution may be a return of capital and various factors will affect the level of the Fund’s income, such...

Continue reading

QCR Holdings, Inc. Welcomes New Directors and Announces a Cash Dividend of $0.06 Per Share

MOLINE, Ill., Aug. 23, 2024 (GLOBE NEWSWIRE) — QCR Holdings, Inc. (NASDAQ: QCRH) (the “Company”) today announced the appointment of James R. Batten and Amy L. Reasner to the Company’s Board of Directors, increasing the Board from 11 to 13 members. The appointments were effective August 21, 2024. “Both Jim and Amy bring a strong background and expertise that complements the composition and experience of our board,” said Larry Helling, Chief Executive Officer. “They also have deep commitments and close ties to the markets that we serve.” Mr. Batten currently serves as Chair of the Board of Directors of Guaranty Bank and previously served as Chair of the Board of Directors of Guaranty Federated Bancshares, Inc., prior to its acquisition by QCR Holdings. He currently serves as President of H2D2, LLC, a family office. His past positions...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.